Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We report a case of HCV-associated stage IV DLBCL successfully treated concurrently using chemoimmunotherapy and a sofosbuvir-based antiviral regimen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170491PMC
http://dx.doi.org/10.1093/ofid/ofw223DOI Listing

Publication Analysis

Top Keywords

chemoimmunotherapy sofosbuvir-based
8
sofosbuvir-based antiviral
8
diffuse large
8
large b-cell
8
b-cell lymphoma
8
hcv infection
8
concurrent systemic
4
systemic chemoimmunotherapy
4
antiviral treatment
4
treatment hepatitis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!